Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
2.650
-0.070 (-2.57%)
At close: Mar 9, 2026, 4:00 PM EDT
2.370
-0.280 (-10.57%)
After-hours: Mar 9, 2026, 6:26 PM EDT
UPC Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 1 | 2 | 6 | 3 | 12 | 54 | |
| Market Cap Growth | -51.32% | -58.99% | 66.62% | -71.82% | -77.13% | - | |
| Enterprise Value | -23 | -37 | 1 | -19 | -12 | 20 | |
| Last Close Price | 2.65 | 4.20 | 146.40 | 570.00 | 2034.00 | 8891.99 | |
| PE Ratio | - | - | - | - | - | 4.75 | |
| PS Ratio | 0.08 | 0.13 | 0.25 | 0.11 | 0.31 | 1.12 | |
| PB Ratio | 0.03 | 0.04 | 0.13 | 0.12 | 0.27 | 0.91 | |
| P/TBV Ratio | 0.03 | 0.04 | 0.13 | 0.12 | 0.27 | 0.91 | |
| P/FCF Ratio | - | - | - | 3.23 | - | - | |
| P/OCF Ratio | - | - | - | 3.10 | - | - | |
| EV/Sales Ratio | - | - | 0.04 | - | - | 0.43 | |
| EV/EBITDA Ratio | - | - | - | - | - | 1.46 | |
| EV/EBIT Ratio | - | - | - | - | - | 1.51 | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.18 | 0.20 | 0.09 | 0.07 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.31 | |
| Debt / FCF Ratio | - | - | - | 5.11 | - | - | |
| Net Debt / Equity Ratio | -0.43 | -0.43 | -0.47 | 0.01 | -0.32 | -0.30 | |
| Net Debt / EBITDA Ratio | 10.15 | 10.15 | 2.85 | -0.06 | 2.30 | -1.24 | |
| Net Debt / FCF Ratio | 4.58 | 4.58 | 2.21 | 0.18 | 10.70 | 1.12 | |
| Asset Turnover | 0.26 | 0.26 | 0.42 | 0.64 | 0.62 | 0.97 | |
| Inventory Turnover | 3.12 | 3.12 | 5.60 | 7.93 | 7.82 | 10.37 | |
| Quick Ratio | 3.55 | 3.55 | 2.33 | 1.33 | 2.60 | 3.36 | |
| Current Ratio | 4.07 | 4.07 | 2.54 | 1.84 | 3.17 | 4.50 | |
| Return on Equity (ROE) | -7.23% | -7.23% | -23.76% | -17.69% | -15.01% | 28.39% | |
| Return on Assets (ROA) | -2.66% | -2.66% | -9.14% | -4.90% | -6.77% | 17.17% | |
| Return on Invested Capital (ROIC) | -9.17% | -10.45% | -30.75% | -13.29% | -19.24% | 41.01% | |
| Return on Capital Employed (ROCE) | -5.20% | -5.20% | -16.80% | -14.20% | -15.10% | 23.10% | |
| Earnings Yield | -245.98% | -155.20% | -151.27% | -190.05% | -64.37% | 21.07% | |
| FCF Yield | -356.31% | -224.81% | -169.04% | 30.98% | -11.36% | -29.02% | |
| Buyback Yield / Dilution | -3174.93% | -3174.93% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.